MannKind Corporation
MNKDNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $986.32M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.23$6.51
- Volume (live)
- -
- Avg. volume (3M)
- 4.98M
MannKind (MNKD) Stock Price & Financial Analysis
MannKind Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.02 - $3.24 |
|---|---|
| 52-Week High | $6.51 |
| 52-Week Low | $2.23 |
| Open | $3.20 |
| Volume (last close) | 2.61M |
| Average Volume (3M) | 4.98M |
| Revenue (TTM) | 393.63M |
|---|---|
| Net Income (TTM) | -43.61M |
| Free Cash Flow (TTM) | -18.14M |
| EPS (TTM) | −$0.14 |
| Profit Margin | -11.08% |
| Operating Margin | 2.18% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 986.32M |
|---|---|
| Shares Outstanding | 309.19M |
| Price to Sales (P/S) | 2.51 |
| Price to Book (P/B) | -14.68 |
| EV/EBITDA | 62.88 |
| 50-Day MA | $3.77 |
|---|---|
| 200-Day MA | $3.88 |
| 1-Year Change | −41.68% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
MannKind at a Glance
As of the Oct 16, 2026 close, MannKind (MNKD) has a market capitalization of $986.32M. The stock trades at 2.5× sales. Over the trailing twelve months it lost $43.61M on revenue of $393.63M and burned $18.14M of free cash flow. Revenue grew 30.5% year over year.
As of its latest reported balance sheet, it holds $52.93M in cash and securities against $321.16M of debt, a net debt position of $268.23M.
MannKind does not currently pay a dividend.
The share price is down 41.7% over the past year. At $3.04 (the Oct 16, 2026 close) it sits within its 52-week range of $2.23 to $6.51, below its 200-day moving average of $3.88.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $7.70, 153.3% above the Oct 16, 2026 close.
Frequently Asked Questions About MannKind
What is the current stock price for MNKD?
As of the Oct 16, 2026 close, MNKD stock trades at $3.04. The 52-week range is $2.23–$6.51, with a day range of $3.02–$3.24.
What is the P/E ratio for MNKD?
The P/E ratio (Price-to-Earnings) for MNKD is shown in the Key Statistics section. This valuation metric helps compare MannKind Corporation to industry peers.
Does MNKD pay dividends?
MannKind does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MNKD?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for MNKD is Buy. The average 12-month price target is $7.70, a 153.3% upside from the Oct 16, 2026 close of $3.04.
What is the market cap of MNKD?
As of the Oct 16, 2026 close, MannKind's market capitalization is $939.9M, classifying it as a small-cap company. MannKind operates in the Healthcare sector within the Biotechnology industry.